Table 1 Transcription errors affect proteins directly implicated in amyloid- and prion-like diseases

From: Transcript errors generate amyloid-like proteins in human cells

Gene

Protein

Disease

Errors detected

Mutations mimicked

Key aa’s affected

Amyloid potential

ABri peptide

ITM2B

FBD and FDD

66

2

6

27

Amyloid precursor protein

APP

Alzheimer’s disease

266

6

9

51

Cystatin-B

CSTB

EPM1

33

2

1

0

Fused in sarcoma

FUS

ALS

25

1

3

10

Gamma-crystallin D

CRYGD

Coralliform cataracts

1

1

0

0

Gelsolin

GSN

FAF

35

1

1

12

Heterogeneous nuclear

ribonucleoprotein D-like

HNRNPDL

Limb-girdle muscular dystrophy 1 G

15

1

1

4

Medin

MFGE8

Cerebrovascular dysfunction

115

1

1

29

Neurofilament heavy polypeptide

NEFH

CMT and ALS

1

1

0

1

Prion protein

PRNP

CJD, GSS, FFI

10

1

1

1

Receptor-interacting

serine/threonine-protein kinase 1

RIPK1

Neuroinflammation

1

1

0

1

Solute carrier family 3

Member 2

SLC3A2

Lysinuric protein intolerance

57

1

0

8

Super oxide dismutase 1

SOD1

ALS

6

1

0

1

Transforming growth factor

beta-induced

TGFBI

Corneal dystrophy

701

6

12

126

Tumor protein 53

TP53

Cancer

60

5

1

3

Transthyretin

TTR

Transthyretin amyloidosis

57

4

9

12

Tubulin alpha-1A chain

TUBA1A

Tubulinopathies

149

3

15

33

  1. Column 1: Gene name. Column 2: Protein symbol. Column 3: Disease associated with protein. Column 4: Number of errors detected in transcripts that were derived from this gene. Column 5: Number of errors that generate mutant proteins identical to those seen in familial cases of protein aggregation diseases. Column 6: Number of errors that affect an amino acid (aa) known to be involved in disease, but mutate it to a different residue compared to the clinic. Column 6: Number of errors that increase the amyloid potential of these proteins as predicted by bioinformatic analysis (AmyPred-FRL).